Valuation: Atrion Corporation

Market Cap 809M 704M 655M 601M 1.14B 77.27B 1.15B 7.72B 3.03B 38.47B 3.04B 2.97B 129B P/E 2022
28.6x
P/E 2023 34.4x
Enterprise Value 803M 698M 650M 597M 1.13B 76.7B 1.14B 7.66B 3.01B 38.18B 3.02B 2.95B 128B EV / Sales 2022
5.27x
EV / Sales 2023 3.9x
Free-Float
50.88%
Yield 2022
1.47%
Yield 2023 2.3%
3 years 274.98
Extreme 274.98
564.21
5 years 274.98
Extreme 274.98
805.62
10 years 274.98
Extreme 274.98
948.03
Manager TitleAgeSince
Corporate Secretary 53 20/08/2024
Director TitleAgeSince
Director/Board Member 53 20/08/2024
Date Insider Type Main position Quantity % Market Cap.
21/08/24 Issuer sale

Director

2,991 0.1699%
21/08/24 Issuer sale

Chief Executive Officer

98,614 5.6032%
21/08/24 Issuer sale

Director

499 0.0284%
Change 5-day change 1-year change 3-year change Capi.($)
+0.06%-.--%-.--%-15.90% 809M
+0.09%+2.56%-16.96%-4.37% 183B
-0.37%+2.62%-4.42%-2.61% 109B
-0.29%+0.47%+7.97%+64.64% 60.57B
+3.50%+0.47%+41.00%+46.44% 51.8B
+0.10%+5.92%-6.10%-40.54% 45.64B
+0.41%+1.37% - - 33.22B
+11.95%+16.65%+5.26%-31.60% 31.49B
+0.40%+3.89%+42.51%-8.26% 24B
-1.22%+6.69%+0.67%+1.96% 22.26B
Average +1.46%+4.37%+7.77%+1.08% 56.2B
Weighted average by Cap. +0.92%+3.48%-0.11%+4.21%

Financials

2022 2023
Net sales 184M 160M 148M 136M 257M 17.52B 261M 1.75B 687M 8.72B 689M 674M 29.24B 169M 147M 137M 126M 238M 16.16B 241M 1.61B 634M 8.05B 636M 622M 26.98B
Net income 35.01M 30.43M 28.33M 26.01M 49.11M 3.34B 49.87M 334M 131M 1.66B 131M 129M 5.58B 19.41M 16.87M 15.71M 14.42M 27.23M 1.85B 27.65M 185M 72.66M 922M 72.9M 71.3M 3.09B
Net Debt -25.21M -21.92M -20.4M -18.73M -35.37M -2.41B -35.92M -240M -94.37M -1.2B -94.68M -92.6M -4.02B -6.02M -5.23M -4.87M -4.47M -8.44M -574M -8.57M -57.38M -22.52M -286M -22.59M -22.1M -959M
Logo Atrion Corporation
Atrion Corporation develops and manufactures products, primarily for medical applications. The Company's medical products are used in a number of fields including fluid delivery, cardiovascular, and ophthalmic applications. It has developed a variety of proprietary valves designed to precisely fill, hold, and release and/or remove controlled amounts of fluids, including blood and drugs, or gasses on demand for use in areas such as intubation, intravenous, catheter, and other applications in fields including anesthesia and oncology. The core of its cardiovascular products is its Myocardial Protection System, a technology that is the only open-heart surgery system that delivers to the heart essential fluids and medications, mixes critical drugs, and controls temperature, pressure, and other important variables. The Company also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults.
Employees
712
  1. Stock Market
  2. Stocks
  3. ATRI Stock